[1] Toi H,Kinoshita K,Hirai S,et al.Present epidemiology of chronic subduralhematoma in Japan:analysis of 63,358 cases recorded in a national administrative database[J].J Neurosurg,2018,128(1):222~228. [2] 孙涛,韩易,姜之全,等.改良护脑双腔引流管在慢性硬膜下血肿外引流术中的应用[J].中华医学杂志,2018,98(45):3681~3685. [3] 陈伟平,钟连英,黄文江,等.改良式单孔引流术治疗慢性硬膜下血肿52例[J].实用医学杂志,2006,22(24):2874~2875. [4] Buchanan IA,Mack WJ.Minimally invasive surgical approaches for chronic subdural hematomas[J].Neuro surg Clin Am,2017,28(2):219~227. [5] Gernsback J,Kolcun JP,Jagid J.To drain or two drains:recurrences in chronic subdural hematomas[J].World Neuro surg,2016,95:447~450. [6] 伍强军,李晓波,舒俊斌,等.改良颅骨钻孔引流治疗慢性硬膜下血肿术后肺部感染及预后不良相关因素分析[J].中国微侵袭神经外科杂志,2018,23(3):119~123. [7] 万力源,秦晓雅,赵晓平,等.微创穿刺术与钻孔引流术治疗慢性硬膜下血肿临床效果的Mate分析[J].实用心脑肺血管病杂志,2019,27(8):20~25. [8] 伍葵,徐善水.不同术式治疗慢性硬膜下血肿的疗效分析[J].立体定向和功能性神经外科杂志,2018,31(1):50~53. [9] You CG,Zheng XS.Postoperative pneumocephalus increases the recurrence rate of chronic subdural hematoma[J].Clin Neurol Neurosurg,2018,166:56~60. [10] 刘海巍,陶胜忠,陈辉,等.慢性硬膜下血肿钻孔引流术术后复发的危险因素分析[J].重庆医学,2018,47(4):528~530. [11] 刘帅,王晓峰,朱峰.高压氧联合阿托伐他汀在慢性硬膜下血肿钻孔手术后的应用[J].中国临床神经外科杂志,2017,22(11):779~780. [12] 刘帅,张荣军,张宏兵.高压氧联合阿托伐他汀治疗慢性硬脑膜下血肿 116 例疗效分析[J].国际神经病学神经外科学杂志,2020,47(4):395~398. [13] 刘超,李明昌,王军民,等.钻孔引流术联合阿托伐他汀钙片治疗慢性硬膜下血肿疗效分析[J].中华神经医学杂志,2018,17(3):295~300. |